The C Terminus of HIV-1 Tat Modulates the Extent of CD178-mediated Apoptosis of T Cells*

HIV infection and the progression to AIDS are characterized by the depletion of CD4+ T cells through apoptosis of the uninfected bystander cells and the direct killing of HIV-infected cells. This is mediated in part by the human immunodeficiency virus, type 1 Tat protein, which is secreted by virally infected cells and taken up by uninfected cells and CD178 gene expression, which is critically involved in T cell apoptosis. The differing ability of HIV strains to induce death of infected and uninfected cells may play a role in the clinical and biological differences displayed by HIV strains. We chemically synthesized the 86-residue truncated short variant of Tat and its full-length form. We show that the trans-activation ability of Tat at the long terminal repeat does not correlate with T cell apoptosis but that the ability of Tat to up-regulate CD178 mRNA expression and induce apoptosis in T cells is critically dependent on the C terminus of Tat. Moreover, the greater 86-residue Tat-induced apoptosis is via the extrinsic pathway of CD95-CD178.

[1]  J. Tschopp,et al.  Inhibition of fas death signals by FLIPs. , 1998, Current opinion in immunology.

[2]  P. Wingfield,et al.  Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation , 1993, Journal of virology.

[3]  H. Xiao,et al.  Selective CXCR4 antagonism by Tat: implications for in vivo expansion of coreceptor use by HIV-1. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[4]  P. Charneau,et al.  Fusion from without directed by human immunodeficiency virus particles , 1994, Journal of virology.

[5]  M. Huigen,et al.  Multiple effects of HIV‐1 trans‐activator protein on the pathogenesis of HIV‐1 infection , 2004, European journal of clinical investigation.

[6]  K. Jeang,et al.  Recombinant human immunodeficiency virus type 1 genomes with tat unconstrained by overlapping reading frames reveal residues in Tat important for replication in tissue culture , 1996, Journal of virology.

[7]  S. Salahuddin,et al.  Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients , 1990, Nature.

[8]  T. Curiel,et al.  Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes , 1995, Nature Medicine.

[9]  J. Alimonti,et al.  Mechanisms of CD4+ T lymphocyte cell death in human immunodeficiency virus infection and AIDS. , 2003, The Journal of general virology.

[10]  P. Krammer,et al.  T cell activation‐induced and HIV Tat‐enhanced CD95(APO‐1 / Fas) ligand transcription involves NF‐κB , 2000 .

[11]  Takashi Suda,et al.  Molecular cloning and expression of the fas ligand, a novel member of the tumor necrosis factor family , 1993, Cell.

[12]  E. Vivés,et al.  Effects of the Tat basic domain on human immunodeficiency virus type 1 transactivation, using chemically synthesized Tat protein and Tat peptides , 1994, Journal of virology.

[13]  K. Dalhoff,et al.  Fas (CD95) expression on CD4+ T cells from HIV-infected patients increases with disease progression , 1995, Journal of Molecular Medicine.

[14]  M. Benkirane,et al.  Tat Protein of Human Immunodeficiency Virus Type 1 Induces Interleukin-10 in Human Peripheral Blood Monocytes: Implication of Protein Kinase C-Dependent Pathway , 2000, Journal of Virology.

[15]  P. Krammer,et al.  Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120 , 1995, Nature.

[16]  I. Herr,et al.  Activation of the CD95 (APO-1/Fas) system in T cells from human immunodeficiency virus type-1-infected children. , 1996, Blood.

[17]  S. Steinberg,et al.  Apoptosis and apoptosis‐associated perturbations of peripheral blood lymphocytes during HIV infection: comparison between AIDS patients and asymptomatic long‐term non‐progressors , 2000, Clinical and experimental immunology.

[18]  M. Schechter,et al.  CD4+ blood lymphocytes are rapidly killed in vitro by contact with autologous human immunodeficiency virus-infected cells. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[19]  H. Xiao,et al.  Interaction of the second coding exon of Tat with human EF-1 delta delineates a mechanism for HIV-1-mediated shut-off of host mRNA translation. , 1998, Biochemical and biophysical research communications.

[20]  Matthias Mann,et al.  FLICE is activated by association with the CD95 death‐inducing signaling complex (DISC) , 1997, The EMBO journal.

[21]  S. Arya,et al.  Trans-activator gene of human T-lymphotropic virus type III (HTLV-III). , 1985, Science.

[22]  S. Nagata,et al.  Fas-mediated apoptosis of CD4+ and CD8+ T cells from human immunodeficiency virus-infected persons: differential in vitro preventive effect of cytokines and protease antagonists. , 1996, Blood.

[23]  S. Nekhai,et al.  HIV-1 Tat interacts with LIS1 protein , 2005, Retrovirology.

[24]  S. Nagata,et al.  Overexpression of Fas antigen on T cells in advanced HIV-1 infection: differential ligation constantly induces apoptosis , 1996, AIDS.

[25]  P. Kaleebu,et al.  The relationship between HIV type 1 disease progression and V3 serotype in a rural Ugandan cohort. , 2004, AIDS Research and Human Retroviruses.

[26]  Junying Yuan,et al.  Human ICE/CED-3 Protease Nomenclature , 1996, Cell.

[27]  A. Capron,et al.  Cell dysfunction and depletion in AIDS: the programmed cell death hypothesis. , 1991, Immunology today.

[28]  C. Van Lint,et al.  Immune Hyperactivation of HIV-1-Infected T Cells Mediated by Tat and the CD28 Pathway , 1997, Science.

[29]  A. Schürmann,et al.  HIV-1 Nef associated PAK and PI3-Kinases stimulate Akt-independent Bad-phosphorylation to induce anti-apoptotic signals , 2001, Nature Medicine.

[30]  Qiang Zhou,et al.  HIV‐1 Tat targets microtubules to induce apoptosis, a process promoted by the pro‐apoptotic Bcl‐2 relative Bim , 2002, The EMBO journal.

[31]  E. Verdin,et al.  Dual role of HIV Tat in regulation of apoptosis in T cells. , 1997, Journal of immunology.

[32]  P. Matarrese,et al.  The HIV-1 vpr Protein Acts as a Negative Regulator of Apoptosis in a Human Lymphoblastoid T Cell Line: Possible Implications for the Pathogenesis of AIDS , 1998, The Journal of experimental medicine.

[33]  P. Kaleebu,et al.  Full-length HIV-1 Tat protein necessary for a vaccine. , 2004, Vaccine.

[34]  Luigi Buonaguro,et al.  HIV‐1 Tat protein exits from cells via a leaderless secretory pathway and binds to extracellular matrix‐associated heparan sulfate proteoglycans through its basic region , 1997, AIDS.

[35]  E. Bouveret,et al.  Tat HIV-1 Primary and Tertiary Structures Critical to Immune Response Against Non-homologous Variants* , 2002, The Journal of Biological Chemistry.

[36]  X. Contreras,et al.  IL-10 production induced by HIV-1 Tat stimulation of human monocytes is dependent on the activation of PKC beta(II) and delta isozymes. , 2004, Microbes and infection.

[37]  T. Rana,et al.  Biochemical and functional interactions between HIV-1 Tat protein and TAR RNA. , 1999, Archives of biochemistry and biophysics.

[38]  Eddy Pasquier,et al.  The Glutamine-rich Region of the HIV-1 Tat Protein Is Involved in T-cell Apoptosis* , 2004, Journal of Biological Chemistry.

[39]  Mark L. Pearson,et al.  Complete nucleotide sequence of the AIDS virus, HTLV-III , 1985, Nature.

[40]  R. F. Smith,et al.  Human Retroviruses and AIDS. A compilation and analysis of nucleic acid and amino acid sequences: I--II; III--V , 1993 .

[41]  Z. Klase,et al.  An in Vivo Replication-important Function in the Second Coding Exon of Tat Is Constrained against Mutation despite Cytotoxic T Lymphocyte Selection* , 2003, Journal of Biological Chemistry.

[42]  P. S. Ho,et al.  Circular dichroism and molecular modeling yield a structure for the complex of human immunodeficiency virus type 1 trans-activation response RNA and the binding region of Tat, the trans-acting transcriptional activator. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[43]  A. Fauci,et al.  Multifactorial nature of human immunodeficiency virus disease: implications for therapy. , 1993, Science.

[44]  S. Bartz,et al.  Human Immunodeficiency Virus Type 1 Tat Induces Apoptosis and Increases Sensitivity to Apoptotic Signals by Up-Regulating FLICE/Caspase-8 , 1999, Journal of Virology.

[45]  M. Lederman,et al.  HIV-1 Tat protein and its inhibitor Ro 24-7429 inhibit lymphocyte proliferation and induce apoptosis in peripheral blood mononuclear cells from healthy donors. , 1996, Cellular immunology.

[46]  V. Metelev,et al.  Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein. , 1995, Science.

[47]  J. Corbeil,et al.  HIV‐induced apoptosis of activated primary CD4+ T lymphocytes is not mediated by Fas–Fas ligand , 1997, AIDS.

[48]  K. Jeang,et al.  Differential acetylation of Tat coordinates its interaction with the co‐activators cyclin T1 and PCAF , 2002, The EMBO journal.

[49]  E. Vivés.  Cellular utake of the Tat peptide: an endocytosis mechanism following ionic interactions , 2003 .

[50]  J. Blenis,et al.  Essential requirement for caspase-8/FLICE in the initiation of the Fas-induced apoptotic cascade , 1998, Current Biology.

[51]  F. Miedema,et al.  Programmed death of T cells in HIV-1 infection. , 1992, Science.

[52]  T. Mak,et al.  Essential role of the mitochondrial apoptosis-inducing factor in programmed cell death , 2001, Nature.

[53]  M. Carré,et al.  HIV-1 Tat protein enhances Microtubule polymerization , 2005, Retrovirology.

[54]  D. Green.  Apoptotic Pathways Paper Wraps Stone Blunts Scissors , 2000, Cell.

[55]  K. Jeang,et al.  Tat as a transcriptional activator and a potential therapeutic target for HIV-1. , 2000, Advances in pharmacology.

[56]  P. Krammer,et al.  HIV-1 Trans-Activator of Transcription Substitutes for Oxidative Signaling in Activation-Induced T Cell Death 1 , 2005, The Journal of Immunology.

[57]  D. Olive,et al.  Full Peptide Synthesis, Purification, and Characterization of Six Tat Variants , 1999, The Journal of Biological Chemistry.